News

Beinn Ghrideag Community Wind Farm, based in the Isle of Lewis, has received £11 million in funding from Santander Corporate & Commercial to build the wind farm and deliver the project’s extensive community-focused business plan. Developed by Point and Sandwick Power, a wholly owned subsidiary of the Point and Sandwick Development Trust (PSDT), Beinn Ghrideag is set to be the UK’s largest 100% community wind farm.

Scottish Enterprise has welcomed the news that four offshore wind farms have received consent from the Scottish Government.

Report calls for talent, innovation and procurement strategy improvements to overcome market challenges

By 2040, investment of around £30 billion is expected in the UK Continental Shelf (UKSC) on decommissioning North Sea oil and gas projects according to a new report commissioned by Decom North Sea and Scottish Enterprise.

Scottish ocean energy companies will be able to bid for a share of a new €7 million funding pot, Energy Minister Fergus Ewing will say today.

Jee Ltd, a leading independent multi-discipline subsea engineering and training firm, has been awarded a contract from Scottish Enterprise to develop subsea electrical array cable solutions for tidal energy installations.

New state-of-the-art Kilmarnock premises and 80 jobs for Scottish-based firm

Almost half of Q1 and Q2 jobs a result of US engagement

Scottish Biopharmaceutical Company MGB Biopharma Secures £4.0m ($6.4m) to Develop New Antibacterial Drug against the Major Global Problem of Antimicrobial Resistance

MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, announces today that it has secured £4.0m ($6.4m) to advance the development of its lead antibacterial, MGB-BP-3, against a range of Gram-positive infections including Clostridium difficile and methicillin-resistant and susceptible Staphylococcus species. MGB-BP-3 is the first novel class of antibacterial for over a decade with a new mode of action to be developed globally. The drug - originally developed at the University of Strathclyde and licensed to MGB Biopharma - could make a real difference in the fight against antimicrobial resistance.